Minister Memişoğlu announced that 64 new human medical products were included in the reimbursement list.

In his statement on his account on NSosyal, Memişoğlu stated that regulations have been made to the drugs on the reimbursement list.

Memişoğlu stated that 64 new human medical products, 51 of which are domestically produced, were included in the list, and noted the following:

The scope of the reimbursement list has been expanded to include five blood products, three COPD medications, four diabetes medications, allergy vaccines, antibiotics, and one biosimilar intraocular medication, along with 14 blood and blood-forming organ medications, six analgesic medications, four anti-inflammatory analgesics, four digestive system medications, two antiparasitic medications, immunosuppressants, ophthalmic preparations, and vitamins, as well as one antifungal, antiviral, and hormone preparation, psycholeptic, hemorrhoid treatment medication, special medical purpose food, and one other human medicinal product. I hope this positive development will be beneficial for all our citizens.